Sleeping aids are drugs & medical devices that are used to diagnose and treat various sleep disorders, like sleep apnea, restless legs syndrome, and insomnia. Sleep is a biological necessity which maintain metabolic homeostasis, effects memory as well as other cognitive function, and controls immune function. Absence of quality sleep leads to sleep disorders, which are due to medical issues, physical disturbances, environmental problems, as well as psychiatric disorders. These sleep disorders have adverse effect on the human health causing number of chronic diseases including diabetes, high blood pressure, arthritis, and stroke. The increasing awareness regarding sleeping aids devices around the globe drives the growth of global sleeping aids market over coming years.The research analyst at AMA estimates Sleeping Aids market to grow at a compounded annual growth rate of 6.8%
AMA Research have segmented the market of Global Sleeping Aids market by Type, Application and Region. On the basis of Type, Mattresses and Pillows are dominating the market in the year 2020 where as Medication stood as second largest market share.
On the basis of application, Insomnia segment is dominating the market in the year 2020
On the basis of geography, the market of Sleeping Aids has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2020.
Evolving Technologies in Sleeping Aid Devices
Increasing Incidence of Sleep Related Disorders, Changing Lifestyle, Tense Work Conditions and Working in Shifts and Growing Geriatric and Obese Population
Untouched Markets in Developing Economies and Rising Awareness Regarding Sleep Disorders
- Hostile Effects of Sleep Aid Medication
In addition to the aforementioned factor, Increasing Incidence of Sleep Related Disorders
is expected to propel the growth of the market over the forecast period.
The key Players profiled in the study are Pfizer Inc. (United States), Takeda Pharmaceutical Company Limited. (Japan), Teva Pharmaceutical Industries Ltd. (Israel), Natus Medical Incorporated (United States), Compumedics Limited (Australia), Merck & Company, Inc.(United States), Sanofi S.A.(France), GlaxoSmithKline Plc (United Kingdom) and Serta International (United States). A lot of United States players are profiled in the research study indicating a strong market dependence.